Clinical Trials

In an age where artificial intelligence continues to pervade every aspect of daily life, the idea of AI chatbots stepping into the realm of psychotherapy is no longer a far-fetched concept. Imagine reaching a point where a simple conversation with a machine could lessen the burden of your anxieties

Schrödinger, a well-established player in the computational chemistry and drug discovery space, has recently made headlines by embracing artificial intelligence (AI). The company’s CEO, Ramy Farid, officially announced this strategic pivot during the presentation of the company's year-end re

Glucose, a simple sugar widely recognized for its role as the primary energy source for most living cells, has recently been discovered to play a critical role beyond its conventional function. In groundbreaking research conducted by a team at Stanford Medicine, glucose has been identified as a

The pharmaceutical landscape is rapidly evolving, and at the forefront of these advancements is Merck & Co.'s groundbreaking licensing agreement with Jiangsu Hengrui Pharmaceuticals, focusing on the innovative Lipoprotein(a) [Lp(a)] inhibitor, HRS-5346. This monumental $2 billion deal puts

Precision medicine offers significant promise in enabling targeted therapies for complex illnesses, making treatment more effective and patient-centered. However, the process of facilitating access and reimbursement for these therapies presents unique challenges. Unlike the more predictable path of

Retinitis pigmentosa, an inherited retinal disease, is characterized by progressive vision loss over time, ultimately leading to severe visual impairment. The disease affects the retinal photoreceptor cells, where the degeneration results in the gradual loss of night vision, peripheral vision, and